期刊文献+
共找到537篇文章
< 1 2 27 >
每页显示 20 50 100
Association between Low-density Lipoprotein Receptor-related Protein 5 Polymorphisms and Type 2 Diabetes Mellitus in Han Chinese:a Case-control Study 被引量:4
1
作者 YOU Hai Fei ZHAO Jing Zhi +11 位作者 ZHAI Yu Jia YIN Lei PANG Chao LUO Xin Ping ZHANG Ming WANG Jin Jin LI Lin Lin WANG Yan WANG Qian WANG Bing Yuan REN Yong Cheng HU Dong Sheng 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2015年第7期510-517,共8页
Objective To investigate the association between low-density lipoprotein receptor-related protein 5 (LRPS) variants (rs12363572 and rs4930588) and type 2 diabetes mellitus (T2DM) in Han Chinese. Methods A total ... Objective To investigate the association between low-density lipoprotein receptor-related protein 5 (LRPS) variants (rs12363572 and rs4930588) and type 2 diabetes mellitus (T2DM) in Han Chinese. Methods A total of 1842 T2DM cases (507 newly diagnosed cases and 1335 previously diagnosed cases) and 7777 controls were included in this case-control study. PCR-RFLP was conducted to detect the genotype of the two single nucleotide polymorphisms (SNPs). Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated to describe the strength of the association by logistic regression. Results In the study subjects, neither rs12363572 nor rs4930588 was significantly associated with T2DM, even after adjusting for relevant covariates. When stratified by body mass index (BMI), the two SNPs were also not associated with T2DM. Among the 3 common haplotypes, only haplotype ~ was associated with reduced risk of T2DM (OR 0.820, 95% CI 0.732-0.919). In addition, rs12363572 was associated with BMI (P〈0.001) and rs4930588 was associated with triglyceride levels (P=0.043) in 507 newly diagnosed T2DM cases but not in healthy controls. Conclusion No LRP5 variant was found to be associated with T2DM in Han Chinese, but haplotype TT was found to be associated with T2DM. 展开更多
关键词 low-density lipoprotein receptor-related protein 5 Gene polymorphism Type 2 diabetes mellitus HAPLOTYPE Metabolic characteristics
下载PDF
ASSOCIATION BETWEEN LOW- DENSITY LIPOPROTEIN RECEPTOR- RELATED PROTEIN GENE, BUTYRYLCHOLINESTERASE GENE AND ALZHEIMER'S DISEASE IN CHINESE 被引量:9
2
作者 毕胜 张昱 +2 位作者 吴江 王德生 赵庆杰 《Chinese Medical Sciences Journal》 CAS CSCD 2001年第2期71-75,共5页
Objective. To research the relations between low- density lipoprotein receptor- related protein gene (LRP) polymorphism, butyrylcholinesterase gene (BchE) polymorphism and Alzheimer’s disease (AD) in Chinese. Methods... Objective. To research the relations between low- density lipoprotein receptor- related protein gene (LRP) polymorphism, butyrylcholinesterase gene (BchE) polymorphism and Alzheimer’s disease (AD) in Chinese. Methods. The gene polymorphisms of LRP and BchE were genotyped in 38 AD cases and 40 controls with polymerase chain reaction- restriction fragment length polymorphism (PCR- RFLP) methods. AD groups were classified according to the LRP C/C genotype and compared with matched controls. Results. AD group had higher frequencies of C/C homozygote (81.6% vs 60.0% , P< 0.05) and of C allele (89.5% vs 76.3% , P< 0.05),with no significant difference between any of these LRP genotypes classified AD groups and their respective control groups. Conclusions. A positive correlation was found between LRP gene polymorphism and AD, but not between BchE gene polymorphism and AD in Chinese AD cases. 展开更多
关键词 阿尔茨海默病 低密度脂蛋白受体相关蛋白基因 丁酰胆碱脂酶基因 基因多态性
下载PDF
Roles of low?density lipoproteinreceptor?related protein 1 in tumors 被引量:4
3
作者 Peipei Xing Zhichao Liao +5 位作者 Zhiwu Ren Jun Zhao Fengju Song Guowen Wang Kexin Chen Jilong Yang 《Chinese Journal of Cancer》 SCIE CAS CSCD 2016年第1期4-11,共8页
Low-density lipoprotein receptor-related protein 1(LRP1,also known as CD91),a multifunctional endocytic and cell signaling receptor,is widely expressed on the surface of multiple cell types such as hepatocytes,fibrobl... Low-density lipoprotein receptor-related protein 1(LRP1,also known as CD91),a multifunctional endocytic and cell signaling receptor,is widely expressed on the surface of multiple cell types such as hepatocytes,fibroblasts,neurons,astrocytes,macrophages,smooth muscle cells,and malignant cells.Emerging in vitro and in vivo evidence demonstrates that LRP1 is critically involved in many processes that drive tumorigenesis and tumor progression.For example,LRP1 not only promotes tumor cell migration and invasion by regulating matrix metalloproteinase(MMP)-2and MMP-9 expression and functions but also inhibits cell apoptosis by regulating the insulin receptor,the serine/threonine protein kinase signaling pathway,and the expression of Caspase-3.LRPI-mediated phosphorylation of the extracellular signal-regulated kinase pathway and c-jun N-terminal kinase are also involved in tumor cell proliferation and invasion.In addition,LRP1 has been shown to be down-regulated by microRNA-205 and methylation of LRP1CpG islands.Furthermore,a novel fusion gene,LRP1-SNRNP25,promotes osteosarcoma cell invasion and migration.Only by understanding the mechanisms of these effects can we develop novel diagnostic and therapeutic strategies for cancers mediated by LRP1. 展开更多
关键词 low-density lipoprotein receptor-related protein 1 Tumorigenesis Invasion migration Proliferation apoptosis Signaling pathway MicroRNA Fusion gene
下载PDF
Expression of Monocyte Chemoattractant Protein-1 in Monocytes and Effects of Native and Oxidized Very Low Density Lipoproteins 被引量:1
4
作者 王国平 邓仲端 倪娟 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 1997年第4期203-205,共3页
Monocyte chemoattractant protein-1(MCP-1), a potent chemoattractant, is thought to play an important role in migration of monocytes into atherosclerotic lesions. The present study was designed to investigate the capac... Monocyte chemoattractant protein-1(MCP-1), a potent chemoattractant, is thought to play an important role in migration of monocytes into atherosclerotic lesions. The present study was designed to investigate the capacity of human peripheral blood monocytes to express MCP-1 and effects of native very low density lipoprotein (VLDL) and oxidized VLDL(OX-VLDL) on the expression. The total RNA was extracted from cultured monocytes, which were exposed to VLDL and OX-VLDL, and the media conditioned by monocytes were collected. MCP-1 mRNA expression was examined by Northern blot analysis. MCP-1 protein in conditioned media was determined by using sandwich ELISA. The results showed that monocytes can express MCP-1 after a 24 h incubation at 37℃,and the expression was markedly increased by a exposure to OX-VLDL, whereas the expression was slightly increased when exposed to VLDL. It suggests that the capacity of monocytes to produce MCP-1 that recruits and activates circulating monocytes may be of considerable importance in atherogenesis, and oxidation of VLDL enhances its potential to promote atherogenesis. 展开更多
关键词 monocyte chemoattractant protein-1 very low density lipoprotein OXIDIZATION MONOCYTES ATHEROSCLEROSIS
下载PDF
Detection of Low Density Lipoprotein Receptor Related Protein Gene Polymorphism and Serum Lipid Levels in Renal Transplant Recipients
5
作者 Yuxin Wang Qingqin Li +4 位作者 Hequn Zou Yuanshan Lu Qinjun Xu Xiaodao Tang Dai Li 《器官移植内科学杂志》 2008年第4期170-175,共6页
关键词 肾移植术 低密度脂蛋白 聚合酶链反应 临床分析
下载PDF
Lipoprotein metabolism in nonalcoholic fatty liver disease 被引量:8
6
作者 Zhenghui Gordon Jiang Simon C. Robson Zemin Yao 《The Journal of Biomedical Research》 CAS 2013年第1期1-13,共13页
Nonalcoholic fatty liver disease (NAFLD), an pathologies characterized by fatty accumulation in escalating health problem worldwide, covers a spectrum of hepatocytes in early stages, with potential progression to li... Nonalcoholic fatty liver disease (NAFLD), an pathologies characterized by fatty accumulation in escalating health problem worldwide, covers a spectrum of hepatocytes in early stages, with potential progression to liver inflammation, fibrosis, and failure. A close, yet poorly understood link exists between NAFLD and dyslipidemia, a constellation of abnormalities in plasma lipoproteins including triglyceride-rich very low density lipoproteins. Apolipoproteins are a group of primarily liver-derived proteins found in serum lipoproteins; they not only play an extracellular role in lipid transport between vital organs through circulation, but also play an important intracellu- lar role in hepatic lipoprotein assembly and secretion. The liver functions as the central hub for lipoprotein metab- olism, as it dictates lipoprotein production and to a significant extent modulates lipoprotein clearance. Lipoprotein metabolism is an integral component of hepatocellular lipid homeostasis and is implicated in the pathogenesis, potential diagnosis, and treatment of NAFLD. 展开更多
关键词 nonalcoholic fatty liver disease (NAFLD) hepatic steatosis nonalcoholic steatohepatitis apolipo-protein lipoprotein metabolism very low density lipoprotein
下载PDF
Lipoprotein in cholesterol transport: Highlights and recent insights into its structural basis and functional mechanism
7
作者 陈淑玉 李娜 +5 位作者 金桃丽 缑璐 郝东晓 田芷淇 张胜利 张磊 《Chinese Physics B》 SCIE EI CAS CSCD 2018年第2期11-20,共10页
Lipoproteins are protein-lipid macromolecular assemblies which are used to transport lipids in circulation and are key targets in cardiovascular disease (CVD). The highly dynamic lipoprotein molecules are capable of... Lipoproteins are protein-lipid macromolecular assemblies which are used to transport lipids in circulation and are key targets in cardiovascular disease (CVD). The highly dynamic lipoprotein molecules are capable of adopting an array of conformations that is crucial to lipid transport along the cholesterol transport pathway, among which high-density lipopro- tein (HDL) and low-density lipoprotein (LDL) are major players in plasma cholesterol metabolism. For a more detailed illustration of cholesterol transport process, as well as the development of therapies to prevent CVD, here we review the functional mechanism and structural basis of lipoproteins in cholesterol transport, as well as their structural dynamics in the plasma lipoprotein (HDL and LDL) elevations, in order to obtain better quantitative understandings on structure-function relationship of lipoproteins. Finally, we also provide an approach for further research on the lipoprotein in cholesterol transport. 展开更多
关键词 cholesterol transport high-density lipoprotein (HDL) low-density lipoprotein (LDL) cholesterylester transfer protein (CETP)
下载PDF
血清S-100B蛋白、可溶性凝集素样氧化低密度脂蛋白受体-1、胶质纤维酸性蛋白检测在新生儿缺血缺氧性脑病病情严重程度中的诊断价值
8
作者 耿淑霞 《陕西医学杂志》 CAS 2024年第1期118-121,共4页
目的:探讨血清S-100B蛋白、可溶性凝集素样氧化低密度脂蛋白受体-1(sLOX-1)、胶质纤维酸性蛋白(GFAP)与新生儿缺血缺氧性脑病(HIE)病情严重程度的关系。方法:选择80例HIE患儿作为观察组,另选择90例健康新生儿作为对照组,收集所有患儿一... 目的:探讨血清S-100B蛋白、可溶性凝集素样氧化低密度脂蛋白受体-1(sLOX-1)、胶质纤维酸性蛋白(GFAP)与新生儿缺血缺氧性脑病(HIE)病情严重程度的关系。方法:选择80例HIE患儿作为观察组,另选择90例健康新生儿作为对照组,收集所有患儿一般资料,并检测两组患儿血清S-100B蛋白、sLOX-1、GFAP水平,分析HIE患儿血清S-100B蛋白、sLOX-1、GFAP与病情严重程度的相关性及预后不良的影响因素。结果:对照组血清S-100B蛋白、sLOX-1、GFAP水平低于观察组(均P<0.05)。重度组血清S-100B蛋白、sLOX-1、GFAP水平高于中度组、轻度组和对照组(均P<0.05)。Pearson相关分析显示,疾病严重程度与HIE患儿血清S-100B蛋白、sLOX-1、GFAP水平呈正相关(均P<0.001)。随访预后良好患儿59例,预后不良21例,经多因素Logistic回归分析显示,产程异常、病情重度、S-100B蛋白、sLOX-1、GFAP为影响HIE患儿预后的危险因素(均P<0.05)。结论:HIE患儿病情严重程度和预后与血清S-100B蛋白、sLOX-1、GFAP水平有关,监测其水平变化有利于临床早期完善干预方案改善预后。 展开更多
关键词 S-100B蛋白 可溶性凝集素样氧化低密度脂蛋白受体-1 胶质纤维酸性蛋白 新生儿缺血缺氧性脑病 相关性 预后
下载PDF
阿托伐他汀联合依洛尤单抗治疗极高风险动脉粥样硬化心血管疾病患者效果的研究
9
作者 郝敬严 刘菁晶 +6 位作者 杨瑞飞 卢宇杰 王雅洁 王群 张健 刘霖泽 林文华 《中国医学创新》 CAS 2024年第9期10-15,共6页
目的:评估阿托伐他汀联合依洛尤单抗治疗极高风险动脉粥样硬化心血管疾病(ASCVD)患者的效果,应用光学相干断层扫描(OCT)测量粥样斑块变化,探讨依洛尤单抗对血管炎症因子的影响。方法:将泰达国际心血管病医院2021年1月—2023年1月冠脉造... 目的:评估阿托伐他汀联合依洛尤单抗治疗极高风险动脉粥样硬化心血管疾病(ASCVD)患者的效果,应用光学相干断层扫描(OCT)测量粥样斑块变化,探讨依洛尤单抗对血管炎症因子的影响。方法:将泰达国际心血管病医院2021年1月—2023年1月冠脉造影检查(CAG)结果为冠状动脉中度狭窄(50%~70%)和低密度脂蛋白胆固醇(LDL-C)升高符合条件的极高风险ASCVD患者60例,按1∶1随机分配到依洛尤单抗组(依洛尤单抗+阿托伐他汀)或标准治疗组(阿托伐他汀),在基线和36周随访时,采用OCT评估靶血管斑块稳定性。结果:治疗36周后,依洛尤单抗组和标准治疗组LDL-C水平均显著降低,依洛尤单抗组低于标准治疗组(P<0.0001)。与标准治疗组相比,依洛尤单抗组最小纤维帽厚度(FCT)差值[(9.41±2.23)μm vs.(21.66±4.46)μm,P<0.001]、靶血管病变最小腔内面积差值[0.13(0.09,0.19)mm^(2) vs.0.23(0.16,0.27)mm^(2),P<0.001]均显著更大,最大脂质弧度差值显著更小[(-8.12±2.40)°vs.(-18.13±3.60)°,P<0.001]。依洛尤单抗组脂蛋白磷脂酶A2(LpA2)更低(P=0.001),而两组C反应蛋白水平(CRP)差异无统计学意义(P=0.574)。此外,标准治疗组中有4例患者发生靶血管血运重建,而依洛尤单抗组发生1例非致死性急性心肌梗死(P=0.098)。未发现药物不良反应事件。结论:阿托伐他汀联用依洛尤单抗可大幅降低血脂LDL-C水平,并明显改善粥样斑块的特征和表型。依洛尤单抗可显著降低血管特异性炎症标志物LpA2水平,或可为ASCVD二级预防及治疗提供新方向。 展开更多
关键词 动脉粥样硬化性心血管疾病 低密度脂蛋白胆固醇 依洛尤单抗 阿托伐他汀 光学相干成像 C反应蛋白 脂蛋白磷脂酶A2
下载PDF
LRP5基因突变导致骨质疏松症-假性胶质瘤综合征一例报告
10
作者 余安琪 王晨秀 +4 位作者 邓颖 黄水金 何文静 霍亚南 林安华 《中华骨质疏松和骨矿盐疾病杂志》 CSCD 北大核心 2024年第2期150-154,共5页
报告一例常染色体隐性遗传发病的骨质疏松症-假性胶质瘤综合征。先证者女性,23岁,父母非近亲结婚,出生后发现双目失明,婴儿期因发现右眼视网膜母细胞瘤行右眼球摘除术,9岁开始反复发生轻微外力骨折,诊断为成骨不全。查体发现脊柱侧凸畸... 报告一例常染色体隐性遗传发病的骨质疏松症-假性胶质瘤综合征。先证者女性,23岁,父母非近亲结婚,出生后发现双目失明,婴儿期因发现右眼视网膜母细胞瘤行右眼球摘除术,9岁开始反复发生轻微外力骨折,诊断为成骨不全。查体发现脊柱侧凸畸形、胸廓畸形、双上肢肘外翻、四肢关节韧带松弛。双能X线吸收检测仪(dual energy X-ray absorptiometry,DXA)骨密度明显低于同龄人,腰椎1-4骨密度Z值-5,左髋骨密度Z值-1.8。X线摄片示全身骨小梁稀疏。Sanger测序显示低密度脂蛋白受体相关蛋白-5(lowdensity lipoprotein receptor-related protein 5,LRP5)基因的6号外显子和23号外显子发生复合杂合突变,导致p.Pro382Leu+p.Cys1611LeufsX33。本文通过文献复习对该病的临床表现和诊疗特点进行讨论及总结,以期帮助临床医生提高对这一疾病的认识。 展开更多
关键词 低密度脂蛋白受体相关蛋白-5 骨质疏松症-假性神经胶质瘤综合征 复合杂合突变
下载PDF
绝经后2型糖尿病LRP5基因多态性与骨量异常的研究
11
作者 黎娅 李军 +3 位作者 李思源 王曦龄 卢韵秋 李子昕 《中国骨质疏松杂志》 CAS CSCD 北大核心 2024年第2期210-215,共6页
目的分析低密度脂蛋白受体相关蛋白5(low density lipoprotein receptor related protein 5,LRP5)rs556442、rs312778位点基因多态性及突变在绝经后女性2型糖尿病(type 2 diabetes mellitus,T2DM)患者中骨量异常的意义。方法收集2021年... 目的分析低密度脂蛋白受体相关蛋白5(low density lipoprotein receptor related protein 5,LRP5)rs556442、rs312778位点基因多态性及突变在绝经后女性2型糖尿病(type 2 diabetes mellitus,T2DM)患者中骨量异常的意义。方法收集2021年5月至2023年5月新疆石河子地区的142例绝经后女性资料进行回顾性分析,分为正常对照组(A组,n=29)、T2DM组(B组,n=30)、骨量降低组(C组,n=28)、骨量降低+T2DM组(D组,n=55)。收集记录相关基线资料,运用全自动生化测定仪测定受试者血糖、血脂及骨代谢指标。通过双能X线骨密度仪测定骨密度(bone mineral density BMD),LRP5基因位点多态性采用飞行时间质谱法(MALDI-TOF-MS)测定,采用SNPscan技术对上述SNP位点进行基因分型。结果①四组基线资料比较,绝经年限、年龄及腰臀比(waist hip ratio,WHR)比较差异具有统计学意义(P<0.05);②与A组相比,B组的空腹血糖(FPG)、糖化血红蛋白(HbA1c)升高(P<0.05);D组的FPG、HbA1c的血清学水平升高,甘油三酯(TG)血清学水平降低(P<0.05);③rs556442位点:与A组相比,D组基因型分布(AA/AG/GG基因型)有统计学意义(P<0.05);rs312778位点组间基因型(CC/CT/TT基因型)及等位基因分布频率均无统计学意义(P>0.05);④rs556442位点:与AA基因型相比,B、C组AG/GG基因型的股骨颈BMD水平降低;D组AG/GG型的HDL血清学水平降低(P<0.05)。rs312778位点:与CC基因型相比,A组HbA1C、FPG血清学水平较CT/TT基因型低(P<0.05);D组CT/TT基因型的低密度脂蛋白(LDL)血清学水平升高(P<0.05);⑤多元线性回归分析:rs556442位点,TG增加是腰L_(1~4)BMD降低的危险因素(P<0.05);rs312778位点,体质量指数(body mass index,BMI)降低是腰L_(1~4)及股骨颈BMD降低的危险因素,TG增加是腰L_(1~4)BMD降低的危险因素(P<0.05);⑥在rs556442、rs312778位点骨量异常与基因型分布均无统计学意义(P>0.05)。结论新疆石河子地区绝经后T2DM女性患者LRP5基因rs556442、rs312778基因位点的突变可能与骨量降低有关。 展开更多
关键词 低密度脂蛋白受体相关蛋白5 绝经女性 基因突变 骨量异常
下载PDF
miR-370-3p和LRP6对胎儿生长受限孕妇的临床诊断价值
12
作者 郭书焕 张青 +1 位作者 马学玲 周斌 《右江医学》 2024年第6期537-543,共7页
目的探讨微小RNA-370-3p(miR-370-3p)和低密度脂蛋白受体相关蛋白6(LRP6)对胎儿生长受限(FGR)孕妇的临床诊断价值。方法选取2020年6月—2022年6月期间产检并确诊为FGR的孕妇96例为观察组,另选取同期产检的健康孕妇96例作为对照组,记录... 目的探讨微小RNA-370-3p(miR-370-3p)和低密度脂蛋白受体相关蛋白6(LRP6)对胎儿生长受限(FGR)孕妇的临床诊断价值。方法选取2020年6月—2022年6月期间产检并确诊为FGR的孕妇96例为观察组,另选取同期产检的健康孕妇96例作为对照组,记录两组分娩孕周、1 min Apgar评分、5 min Apgar评分、新生儿体重、胎盘质量,依据美国妇产科学院(ACOG)标准将观察组划分为FGR组、严重FGR组。qRT-PCR法检测血清miR-370-3p和LRP6 mRNA表达水平;血清miR-370-3p和LRP6 mRNA水平与分娩孕周、1 min Apgar评分、5 min Apgar评分、新生儿体重、胎盘质量的相关性采用Pearson法分析;miR-370-3p和LRP6 mRNA对FGR的诊断价值采用ROC曲线评估。结果两组孕妇年龄、分娩孕周、是否初产的比例差异有统计学意义(P<0.05);观察组miR-370-3p显著高于对照组,LRP6显著低于对照组(P<0.05);严重FGR组miR-370-3p显著高于FGR组,LRP6显著低于FGR组(P<0.05);对照组与观察组新生儿体重、1 min Apgar评分、5 min Apgar评分及胎盘质量之间差异有统计学意义(P<0.05);miR-370-3p与LRP6之间呈负相关(r=-0.692,P<0.05),miR-370-3p与分娩孕周、新生儿体重、1 min Apgar评分、5 min Apgar评分、胎盘质量均呈负相关(r=-0.401、-0.382、-0.425、-0.484、-0.504,均P<0.05),LRP6与分娩孕周、新生儿体重、1 min Apgar评分、5 min Apgar评分、胎盘质量均呈正相关(r=0.306、0.412、0.512、0.612、0.419,均P<0.05);ROC曲线显示,miR-370-3p对FGR诊断的AUC为0.877(95%CI:0.821~0.919),截断值为1.40,其敏感度、特异性分别为67.71%、93.75%;LRP6对FGR诊断的AUC为0.838(95%CI:0.778~0.887),截断值为0.83,其敏感度、特异性分别为84.37%、71.87%;二者联合对FGR诊断的AUC为0.923(95%CI:0.875~0.956),明显高于二者单独诊断(Z联合vs miR-370-3P=2.811、P=0.005;Z联合vs LRP6=3.372、P=0.001),其敏感度、特异性分别为85.42%、87.50%。结论FGR患者血清miR-370-3p高表达、LRP6低表达,二者联合对FGR具有一定诊断价值。 展开更多
关键词 微小RNA-370-3p 低密度脂蛋白受体相关蛋白6 胎儿生长受限 诊断
下载PDF
氧化低密度脂蛋白通过PCSK9/LRP1信号途径促神经细胞凋亡的双向调节
13
作者 何乃琪 赵雪珊 +5 位作者 徐倩 张华玉 任重 唐志晗 向琼 刘录山 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2024年第4期944-958,共15页
目的阿尔茨海默病(Alzheimer's disease,AD)是多种危险因素引起的中枢神经系统退行性疾病,其中神经细胞凋亡是其主要病理基础之一。高脂血症是AD发生的高危因素,可导致脑组织内氧化低密度脂蛋白(oxidized lowdensity lipoprotein,ox... 目的阿尔茨海默病(Alzheimer's disease,AD)是多种危险因素引起的中枢神经系统退行性疾病,其中神经细胞凋亡是其主要病理基础之一。高脂血症是AD发生的高危因素,可导致脑组织内氧化低密度脂蛋白(oxidized lowdensity lipoprotein,ox-LDL)水平增高。前蛋白转化酶枯草溶菌素9(proprotein convertase subtilisin kexin type 9,PCSK9)是一个与血脂代谢密切相关的蛋白酶,但有研究显示其与AD发生可能相关。本研究旨在探索PCSK9在介导ox-LDL促神经细胞凋亡中的作用及其机制,进一步阐述高脂血症导致AD等神经退行性疾病的发生机制。方法首先用不同浓度ox-LDL(0、25、50、75、100 mg/L)处理PC12细胞24 h,油红O染色检测PC12细胞脂质蓄积,Hoechst33258染色和流式细胞术检测PC12细胞凋亡,ELISA检测PC12分泌的β淀粉样肽(amyloidβ-peptide,Aβ)含量,蛋白质印迹(Western blot)法检测SREBP2、PCSK9和LRP1的表达。然后用75 mg/L ox-LDL处理PC12细胞不同时间(0、6、12、24、48 h),Western blot检测SREBP2、PCSK9和LRP1的表达情况。最后,100 nmol/L PCSK9 siRNA转染PC12细胞48 h后,用75 mg/L ox-LDL处理PC12细胞24 h,Hoechst33258染色和流式细胞术检测PC12细胞的凋亡率,Western blot检测PCSK9、LRP1、PI3K、AKT、P-PI3K、P-AKT、NF-κB、Bcl-2、Bax、Caspase-9和Caspase-3的表达,ELISA检测PC12细胞的Aβ分泌量。结果ox-LDL可以增加PC12细胞脂质蓄积,促进PC12细胞凋亡和Aβ分泌,同时增加PC12细胞中SREBP2和PCSK9的表达,减少LRP1的表达。敲低PCSK9的表达可以通过PI3K/AKT通路和NF-κB-Bcl-2/Bax-Caspase-9/3通路减弱ox-LDL诱导的PC12细胞凋亡,同时增加PC12细胞中Aβ的分泌。结论ox-LDL通过诱导PC12细胞中PCSK9表达增加,降低LRP1的表达,进而影响下游的不同信号途径,从而在ox-LDL诱导PC12细胞凋亡中发挥双向调节作用。 展开更多
关键词 氧化低密度脂蛋白 前蛋白转化酶枯草溶菌素9 低密度脂蛋白受体相关蛋白1 神经细胞 细胞凋亡
下载PDF
院内制剂降脂胶囊治疗颈动脉粥样硬化斑块患者的疗效及对血液流变学的影响分析
14
作者 姜雄 陈军 +2 位作者 王海燕 苟明琴 罗均 《中国实用医药》 2024年第9期113-116,共4页
目的分析遵义市中医院院内制剂降脂胶囊治疗颈动脉粥样硬化斑块患者的疗效及对血液流变学的影响。方法选取252例颈动脉粥样硬化斑块患者,按随机数字表法分为普通组与自制组,每组126例。普通组常规给予阿托伐他汀治疗,自制组在普通组用... 目的分析遵义市中医院院内制剂降脂胶囊治疗颈动脉粥样硬化斑块患者的疗效及对血液流变学的影响。方法选取252例颈动脉粥样硬化斑块患者,按随机数字表法分为普通组与自制组,每组126例。普通组常规给予阿托伐他汀治疗,自制组在普通组用药基础上加用院内制剂降脂胶囊开展治疗。比较两组颈动脉斑块情况[斑块体积(PV)、颈动脉内膜-中层厚度(IMT)及Crouse积分]、血脂指标[总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)及高密度脂蛋白胆固醇(HDL-C)]、实验室指标[超敏C反应蛋白(hs-CRP)、低密度脂蛋白受体相关蛋白-6(LRP-6)]及血液流变学指标。结果自制组用药后PV(45.33±1.74)mm^(3)、IMT(1.08±0.13)mm及Crouse积分(4.72±0.36)分均低于普通组的(57.26±2.45)mm^(3)、(1.52±0.19)mm、(5.34±0.42)分(P<0.05)。自制组用药后TC(3.17±0.42)mmol/L、TG(1.24±0.27)mmol/L及LDL-C(1.39±0.20)mmol/L均低于普通组的(4.01±0.76)、(1.60±0.29)、(2.03±0.35)mmol/L,HDL-C(1.73±0.25)mmol/L显著高于普通组的(1.32±0.13)mmol/L(P<0.05)。自制组用药后hs-CRP水平(4.13±0.52)mg/L低于普通组的(7.58±1.06)mg/L,LRP-6水平(15.67±2.34)ng/ml高于普通组的(12.33±2.01)ng/ml(P<0.05)。自制组用药后全血高切粘度(4.72±0.83)mPa·s、全血低切粘度(9.02±1.71)mPa·s及血浆粘度(1.52±0.18)mPa·s均低于普通组的(6.12±1.81)、(10.31±1.48)、(1.73±0.16)mPa·s(P<0.05)。结论院内制剂降脂胶囊用于颈动脉粥样硬化斑块患者临床治疗中具有确切疗效,可显著改善其血液流变学。 展开更多
关键词 院内制剂 降脂胶囊 颈动脉粥样硬化斑块 血液流变学 血脂代谢 低密度脂蛋白受体相关蛋白-6
下载PDF
LRP1B对Lewis细胞增殖、迁移、侵袭及免疫微环境的影响
15
作者 李艳 闫屹 +4 位作者 嵇桂娟 张文辉 赵力 陈碧 陈昊 《徐州医科大学学报》 CAS 2024年第2期100-105,共6页
目的探讨LRP1B基因对Lewis肺癌细胞增殖、迁移、侵袭及免疫微环境的影响。方法采用TCGA数据库分析LRP1B基因在肺癌及其他癌种中的表达情况。使用CRISPR/Cas9技术构建LRP1B敲除的Lewis细胞(KO组),选择野生型Lewis细胞作为对照组(NC组)。... 目的探讨LRP1B基因对Lewis肺癌细胞增殖、迁移、侵袭及免疫微环境的影响。方法采用TCGA数据库分析LRP1B基因在肺癌及其他癌种中的表达情况。使用CRISPR/Cas9技术构建LRP1B敲除的Lewis细胞(KO组),选择野生型Lewis细胞作为对照组(NC组)。免疫印迹法验证上述2组细胞中LRP1B蛋白的表达。采用CCK-8法检测细胞存活率,划痕实验和细胞侵袭实验检测细胞的迁移和侵袭能力。将制备好的KO组或NC组细胞悬液注射到C57BL/6小鼠右侧腋窝皮下,分别标记为KO组小鼠和NC组小鼠,观察小鼠皮下移植瘤生长情况,流式细胞术检测荷瘤小鼠移植瘤中骨髓源性抑制细胞(MDSC)和CD8^(+)T细胞浸润的变化,免疫组化法检测程序性死亡受体-1(PD-1)及其配体(PD-L1)的水平。结果LRP1B基因在肺腺癌和肺鳞癌组织中的表达水平明显高于癌旁组织。与NC组细胞相比,LRP1B基因敲除后KO组细胞的增殖、迁移和侵袭能力均显著增加(P<0.05)。与NC组小鼠相比,KO组小鼠形成的移植瘤体积明显增加(P<0.05);移植瘤中MDSC比例显著增加、CD8^(+)T细胞比例减少,PD-L1、PD-1表达水平显著增加(P<0.05)。结论LRP1B基因敲除可促进Lewis肺癌细胞的增殖、迁移和侵袭能力,促进PD-L1、PD-1表达。 展开更多
关键词 肺癌 低密度脂蛋白受体相关蛋白1B 免疫微环境 免疫浸润细胞 程序性死亡配体1 程序性死亡受体-1
下载PDF
2型糖尿病患者血清PTX3、sTWEAK水平与非酒精性脂肪性肝病的关系研究
16
作者 赵戬 朱贺 侯丹 《检验医学与临床》 CAS 2024年第7期907-911,917,共6页
目的探讨2型糖尿病(T2DM)患者血清正五聚蛋白3(PTX3)、可溶性肿瘤坏死因子样凋亡弱诱导因子(sTWEAK)水平与非酒精性脂肪性肝病(NAFLD)的关系。方法选取北部战区总医院152例新诊断为T2DM的患者为研究对象,根据是否合并NAFLD将患者分为NA... 目的探讨2型糖尿病(T2DM)患者血清正五聚蛋白3(PTX3)、可溶性肿瘤坏死因子样凋亡弱诱导因子(sTWEAK)水平与非酒精性脂肪性肝病(NAFLD)的关系。方法选取北部战区总医院152例新诊断为T2DM的患者为研究对象,根据是否合并NAFLD将患者分为NAFLD组(92例)和非NAFLD组(60例);根据肝脏超声检查结果,将NAFLD患者分为轻度组、中度组和重度组。另选取35例健康人作为对照(对照组)。采用酶联免疫吸附试验检测血清PTX3、sTWEAK水平。采用Pearson相关分析T2DM患者PTX3和sTWEAK水平与总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、空腹血糖(FPG)、糖化血红蛋白(HbA1c)、胰岛素抵抗指数(HOMA-IR)的关系。采用多因素Logistic回归分析T2DM合并NAFLD的影响因素;采用受试者工作特征(ROC)曲线分析PTX3、sTWEAK对NAFLD的预测价值,计算曲线下面积(AUC)。比较轻度组、中度组、重度组血清PTX3、sTWEAK水平。结果与对照组比较,NAFLD组和非NAFLD组血清PTX3、sTWEAK水平较高(P<0.05)。与非NAFLD组比较,NAFLD组血清PTX3、sTWEAK水平较高(P<0.05)。体质量指数(BMI,OR=3.387)、TG(OR=1.958)、HOMA-IR(OR=3.040)、PTX3(OR=4.836)、sTWEAK(OR=4.133)是T2DM合并NAFLD的影响因素(P<0.05)。T2DM患者血清PTX3水平分别与BMI、LDL-C、FPG、HbA1c、HOMA-IR呈正相关(P<0.05),而与HDL-C呈负相关(P<0.05)。血清sTWEAK水平分别与LDL-C、FPG、HOMA-IR呈正相关(P<0.05)。血清PTX3、sTWEAK预测T2DM患者发生NAFLD的AUC分别为0.873和0.821,二者联合可将AUC提高至0.915。轻度组、中度组、重度组血清PTX3和sTWEAK水平比较,差异有统计学意义(P<0.05),病情越重,患者血清PTX3和sTWEAK水平越高。结论PTX3、sTWEAK是T2DM患者发生NAFLD的影响因素,并且血清PTX3、sTWEAK水平越高,NAFLD病情越重。 展开更多
关键词 2型糖尿病 正五聚蛋白3 可溶性肿瘤坏死因子样凋亡弱诱导因子 非酒精性脂肪性肝病 总胆固醇 甘油三酯 低密度脂蛋白胆固醇
下载PDF
血浆sLRP-1水平对急性冠状动脉综合征患者预后的预测价值研究
17
作者 许皓莉 《罕少疾病杂志》 2024年第1期57-59,共3页
目的研究血浆可溶性低密度脂蛋白受体相关蛋白-1(sLRP-1)判断急性冠状动脉综合征患者预后的价值。方法通过回顾性分析法选择我院2020年8月-2022年5月收住的急性冠状动脉综合征患者157例进入试验,统计并整理所有患者的临床资料,对比不同... 目的研究血浆可溶性低密度脂蛋白受体相关蛋白-1(sLRP-1)判断急性冠状动脉综合征患者预后的价值。方法通过回顾性分析法选择我院2020年8月-2022年5月收住的急性冠状动脉综合征患者157例进入试验,统计并整理所有患者的临床资料,对比不同冠脉狭窄程度患者的sLRP-1水平,同时比较不同sLRP-1水平患者的不良心血管事件的发生率,观察是否发生不良心血管事件患者的临床资料,将有差异项目通过Logistic回归方程计算,分析影响患者预后的风险因素。结果轻度组sLRP-1水平低于中度、重度组(P<0.05)。两组在年龄、患病至就诊时间、sLRP-1、射血分数(LVEF)、低密度脂蛋白(LDL-C)、空腹血糖上存在显著差别(P<0.05),经Logistics回归方程计算,发现上述指标均成为影响患者预后的风险因素。sLRP-1>0.8mg/L组不良心血管事件发生率高于<0.40mg/L组、0.40-0.8mg/L组(P<0.05)。结论sLRP-1成为判断患者预后的重要指标,能够准确评估患者冠脉狭窄程度,预测不良心血管事件发生的风险,值得推广。 展开更多
关键词 急性冠状动脉综合征 可溶性低密度脂蛋白受体相关蛋白-1 预测价值 预后
下载PDF
lncRNA NEAT1调节miR-424-5p/ELK4轴对ox-LDL诱导的血管内皮细胞损伤、Lp-PLA2和CRP水平的影响
18
作者 陈光远 边毓尧 王秀艳 《中西医结合心脑血管病杂志》 2024年第4期653-659,共7页
目的:探讨长链非编码RNA核旁斑组装转录本1(lncRNA NEAT1)在氧化型低密度脂蛋白(ox-LDL)诱导的血管内皮细胞损伤中的分子机制和功能。方法:收集健康人和动脉粥样硬化(AS)病人血液标本并通过实时荧光定量逆转录聚合酶链式反应(qRT-PCR)... 目的:探讨长链非编码RNA核旁斑组装转录本1(lncRNA NEAT1)在氧化型低密度脂蛋白(ox-LDL)诱导的血管内皮细胞损伤中的分子机制和功能。方法:收集健康人和动脉粥样硬化(AS)病人血液标本并通过实时荧光定量逆转录聚合酶链式反应(qRT-PCR)检测血清中lncRNA NEAT1、微小RNA-424-5p(miR-424-5p)和ETS域蛋白4(ELK4)mRNA表达水平。体外培养人脐静脉内皮细胞(HUVEC),qRT-PCR和蛋白免疫印迹法(Western Blot)检测细胞中lncRNA NEAT1、miR-424-5p和ELK4表达情况;细胞计数试剂盒(CCK-8)法和膜联蛋白V-异硫氰酸荧光素/碘化丙啶(Annexin V-FITC/PI)法检测HUVEC细胞增殖活力和凋亡情况;酶联免疫吸附法(ELISA)测定HUVEC中乳酸脱氢酶(LDH)释放量、肿瘤坏死因子-α(TNF-α)和白细胞介素(IL)-1β含量、脂蛋白磷脂酶A2(Lp-PLA2)和C反应蛋白(CRP)水平;采用双荧光素酶报告基因测定lncRNA NEAT1、miR-424-5p和ELK4之间的靶向相互作用。进行动物实验以评估lncRNA NEAT1在体内AS进展中的作用。结果:lncRNA NEAT1在AS病人血清和ox-LDL诱导的HUVEC中显著上调(P<0.05)。lncRNA NEAT1的沉默可削弱ox-LDL引发的细胞毒性,降低Lp-PLA2和CRP水平,并减少ApoE^(-/-)小鼠的脂质异常分泌(P<0.05)。miR-424-5p是lncRNA NEAT1在调节ox-LDL诱导的HUVEC损伤中的功能介质,ELK4是miR-424-5p的直接靶标(P<0.05)。miR-424-5p的抑制或ELK4的过表达逆转了lncRNA NEAT1沉默对ox-LDL诱导的HUVEC细胞损伤的影响(P<0.05)。结论:沉默lncRNA NEAT1可通过调控miR-424-5p/ELK4轴保护HUVEC免受ox-LDL触发的细胞毒性,降低Lp-PLA2和CRP水平。 展开更多
关键词 动脉粥样硬化 长链非编码RNA核旁斑组装转录本1 lncRNA NEAT1 氧化型低密度脂蛋白 微小RNA-424-5p ETS域蛋白4 实验研究
下载PDF
Mechanisms of dysregulation of low-density lipoprotein receptor expression in HepG2 cells induced by inflammatory cytokines 被引量:5
19
作者 CHEN Ya-xi RUAN Xiong-zhong +3 位作者 HUANG Ai-long LI Qiu John F. Moorhead Zac Varghese 《Chinese Medical Journal》 SCIE CAS CSCD 2007年第24期2185-2190,共6页
Background Low-density lipoprotein (LDL) receptor is normally regulated via a feedback system that is dependent on intracellular cholesterol levels. We have demonstrated that cytokines disrupt cholesterol-mediated L... Background Low-density lipoprotein (LDL) receptor is normally regulated via a feedback system that is dependent on intracellular cholesterol levels. We have demonstrated that cytokines disrupt cholesterol-mediated LDL receptor feedback regulation causing intracellular accumulation of unmodified LDL in peripheral cells. Liver is the central organ for lipid homeostasis. The aim of this study was to investigate the regulation of cholesterol exogenous uptake via LDL receptor and its underlying mechanisms in human hepatic cell line (HepG2) cells under physiological and inflammatory conditions. Methods Intracellular total cholesterol (TC), free cholesterol (FC) and cholesterol ester (CE) were measured by an enzymic assay. Oil Red O staining was used to visualize lipid droplet accumulation in cells. Total cellular RNA was isolated from cells for detecting LDL receptor, sterol regulatory element binding protein (SREBP)-2 and SREBP cleavage-activating protein (SCAP) mRNA levels using real-time quantitative PCR. LDL receptor and SREBP-2 protein expression were examined by Western blotting. Confocal microscopy was used to investigate the translocation of SCAP-SREBP complex from the endoplasmic reticulum (ER) to the Golgi by dual staining with anti-human SCAP and anti-Golgin antibodies. Results LDL loading increased intracellular cholesterol level, thereby reduced LDL receptor mRNA and protein expression in HepG2 cells under physiological conditions. However, interleukin 1β (IL-1β) further increased intracellular cholesterol level in the presence of LDL by increasing both LDL receptor mRNA and protein expression in HepG2. LDL also reduced the SREBP and SCAP mRNA level under physiological conditions. Exposure to IL-1β caused over-expression of SREBP-2 and also disrupted normal distribution of SCAP-SREBP complex in HepG2 by enhancing translocation of SCAP-SREBP from the ER to the Golgi despite a high concentration of LDL in the culture medium. Conclusions IL-1β disrupts cholesterol-mediated LDL receptor feedback regulation by enhancing SCAP-SREBP complex translocation from the ER to the Golgi, thereby increasing SREBP-2 mediated LDL receptor expression even in the presence of high concentration of LDL. This results in LDL cholesterol accumulation in hepatic cells via LDL receptor pathway under inflammatory stress. 展开更多
关键词 low-density lipoprotein receptor CYTOKINES sterol regulatory element binding protein-2 SREBP cleavage-activating protein CHOLESTEROL
原文传递
Minimally modified low-density lipoprotein induces monocyte chemotactic protein-1 expression in vivo and a novel model for monocyte adhesion to arterial intima
20
作者 肖丹华 王宗立 佘铭鹏 《Chinese Medical Journal》 SCIE CAS CSCD 1999年第5期54-58,共5页
ObjectiveTotestwhetherminimalymodifiedlowdensitylipoprotein(MMLDL)canstimulatethearterialcelsexpressingMCP... ObjectiveTotestwhetherminimalymodifiedlowdensitylipoprotein(MMLDL)canstimulatethearterialcelsexpressingMCP1invivoandthusin... 展开更多
关键词 MINIMALLY MODIFIED low density lipoprotein · MONOCYTE chemotactic protein 1 · MONOCYTE · atherosclerosis
原文传递
上一页 1 2 27 下一页 到第
使用帮助 返回顶部